Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Bacterin International Holdings Inc. (BONE) to Report 7th Straight Quarter of Record Revs 0 comments
    Jul 18, 2011 5:35 PM | about stocks: BONE

    Bacterin International Holdings Inc., a developer, manufacturer and marketer of biologics products for medical applications, is preparing to report its seventh consecutive quarter of record revenue growth.

     

    Based on preliminary unaudited information, the company said it expects to report second quarter 2011 revenue of approximately $7.5 million, a 134 percent increase compared to $3.2 million reported in the same year-ago quarter.

     

    Bacterin attributes the revenue increase to growth in the number of domestic hospitals and new international accounts using Bacterin products, which stem from the company’s expanding direct and outside sales forces.

     

    Guy Cook, Bacterin chairman and CEO, said the record revenue also reflects the significant operational process made during the quarter, including the launch of the company’s third human acellular biological scaffold.

     

    “We expect this revenue momentum and domestic and international market expansion to continue building throughout the rest of the year, especially with the recent addition of Bacterin’s product line to ROI’s nationwide network of hospitals and medical practices,” Cook stated in the press release. “We also plan to leverage our direct sales force with new product lines that complement existing ones.”

     

    The company successfully increased its working capital, which it will use for further product development, as well as to enhance its recently acquired Robinson MedSurg orthopedic implants with Bacterin anti-microbial coating technology.

     

    Bacterin said it plans on submitting an application later this year to get FDA approval for its anti-microbial coatings technology.

     

    For more information visit bacterin.com

     

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

     

    Stocks: BONE
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.